Jatrosom

Tranylcypromine, the active ingredient in Jatrosom, is a monoamine oxidase inhibitor presented as an oral tablet for oral use. It is prescribed for the treatment of major depressive disorder in adult patients, helping to alleviate persistent depressive symptoms by increasing the availability of key neurotransmitters in the brain.

GNH USA supplies Jatrosom as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide, ensuring consistent quality, regulatory compliance and reliable supply chain support for all therapeutic needs.

Tranylcypromine is an MAOI antidepressant used in the management of depressive disorders.

- Major depressive disorder: reduces depressive symptoms and improves mood in adult patients. - Treatment‑resistant depression: may be considered when other antidepressants have failed. - Atypical depression: can alleviate symptoms such as low energy and mood lability.

Tranylcypromine may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: frequent dull or throbbing pain. - Insomnia: difficulty falling or staying asleep. - Dizziness: sensation of light‑headedness, especially on standing. - Dry mouth: reduced salivation. - Orthostatic hypotension: drop in blood pressure upon standing.

Serious or Rare Side Effects: - Hypertensive crisis: severe high blood pressure after ingesting tyramine‑rich foods. - Serotonin syndrome: potentially life‑threatening condition when combined with other serotonergic agents. - Severe liver injury: rare hepatic toxicity. - Persistent severe hypotension: marked drop in blood pressure requiring medical attention.

Use of Tranylcypromine requires careful monitoring and patient education.

- Avoid tyramine‑rich foods: prevent hypertensive reactions. - Monitor blood pressure regularly: detect orthostatic changes. - Assess liver function: watch for signs of hepatic toxicity. - Use caution in elderly patients: increased risk of falls and hypotension. - Discontinue before surgery: reduce risk of intra‑operative hypertensive episodes. - Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Tranylcypromine interacts with several drug classes and substances.

Major Interactions (Avoid): - Tyramine‑containing foods and beverages: can trigger hypertensive crisis. - Selective serotonin reuptake inhibitors (SSRIs) and SNRIs: risk of serotonin syndrome. - Meperidine and other opioid analgesics: may cause severe hypertension. - Linezolid and other MAO‑inhibiting antibiotics: increase serotonin toxicity. - Certain sympathomimetic agents (e.g., pseudoephedrine): elevate blood pressure.

Moderate Interactions (Monitor Closely): - Antihypertensive medications: may enhance hypotensive effects. - Over‑the‑counter cold remedies containing decongestants: monitor blood pressure and serotonin levels.